Mingming Chen

Mingming Chen is a Neuroscience Postdoctoral Associate at Yale School of Medicine. His research focuses on glial responses, synaptic function, and neuroinflammation, with a particular emphasis on astrocyte reactivation in depression, stroke recovery, and neurodegenerative diseases. He holds a PhD in Neuropharmacology from China Pharmaceutical University (2020), an MS in Pharmacology (2014), and a BS in Pharmacy (2008).

Education:

• PhD, China Pharmaceutical University, Neuropharmacology (2020)
• MS, China Pharmaceutical University, Pharmacology (2014)
• BS, Bengbu Medical College, Pharmacy (2008)

Research Interests: Chen explores mechanisms linking glial activity to synaptic dysfunction and neurodegeneration. His work spans neuroinflammation in depression, stroke recovery via CD200/CD200R signaling, and the role of astrocytes in traumatic brain injury. He also investigates liver disease mechanisms using pharmacological interventions like oridonin and melatonin.

Key Research Themes:

• PET imaging of neurodegenerative biomarkers (e.g., Parthanatos, tau)
• Neuroprotective strategies for Parkinson’s, Alzheimer’s, and stroke
• Interactions between systemic inflammation and central nervous system dysfunction

Advising/Grants: No specific grants or advisees listed. Research activities are primarily lab-based.

Labs/Teams: Affiliated with Yale School of Medicine Neuroscience departments, focusing on translational neuroimaging and molecular pharmacology.